In the randomised controlled FOCUS trial , adult patients aged 50 years and older , with a history of or risk factors for cardiovascular disease , and with postoperative haemoglobin concentrations lower than 100 g/L within 3 days of surgery to repair a hip fracture , were eligible for enrolment .